Isoniazid preventive therapy for postrenal transplant tuberculosis: A systematic review

Reviews and Research in Medical Microbiology

Volumn 22, Issue 1, 2011, Pages 5-11

  Wang, Xianding ^a   Zhuang, Jing ^b   Xie, Libo ^a   Li, Mingyuan ^c,d   Lu, Yiping ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c West China School of Preclinic and Forensic Medicine   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Isoniazid; kidney transplantation; preventive therapy; tuberculosis

Indexed keywords

ISONIAZID;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; EXTRAPULMONARY TUBERCULOSIS; HEPATITIS; HUMAN; INCIDENCE; KIDNEY TUBERCULOSIS; MEDICAL RESEARCH; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; REVIEW; SYSTEMATIC REVIEW;

EID: 78751601123     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MRM.0b013e3283410434     Document Type: Review

References (39)

1. Jassal MS, Bishai WR. Epidemiology and challenges to the elimination of global tuberculosis. Clin Infect Dis 2010; 50(Suppl 3):S156-S164.
2. Glaziou P, Floyd K, Raviglione M. Global burden and epidemiology of tuberculosis. Clin Chest Med 2009; 30:621-636; vii.
3. Subramanian A, Dorman S. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4):S57-S62.
4. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998; 27:1266-1277.
5. Kumar D, Humar A. Tuberculosis and transplantation: battling the opportunist. Clin Infect Dis 2009; 48:1666-1668.
6. Klote MM, Agodoa LY, Abbott K. Mycobacterium tuberculosis infection incidence in hospitalized renal transplant patients in the United States, 1998-2000. Am J Transplant 2004; 4:1523-1528.
7. Garcia-Goez JF, Linares L, Benito N, Cervera C, Cofan F, Ricart MJ, et al. Tuberculosis in solid organ transplant recipients at a tertiary hospital in the last 20 years in Barcelona, Spain. Transplant Proc 2009; 41:2268-2270.
8. Guida JP, Bignotto Rosane D, Urbini-Santos C, Alves-Filho G, Ribeiro Resende M, Mazzali M. Tuberculosis in renal transplant recipients: a Brazilian center registry. Transplant Proc 2009; 41:883-884.
9. Chen SY, Wang CX, Chen LZ, Fei JG, Deng SX, Qiu J, et al. Tuberculosis in southern Chinese renal-transplant recipients. Clin Transplant 2008; 22:780-784.
10. Rungruanghiranya S, Ekpanyaskul C, Jirasiritum S, Nilthong C, Pipatpanawong K, Mavichak V. Tuberculosis in Thai renal transplant recipients: a 15-year experience. Transplant Proc 2008; 40:2376-2379.
11. Ram R, Swarnalatha G, Prasad N, Dakshinamurty KV. Tuberculosis in renal transplant recipients. Transpl Infect Dis 2007; 9:97-101.
12. Naqvi A, Rizvi A, Hussain Z, Hafeez S, Hashmi A, Akhtar F, et al. Developing world perspective of posttransplant tuberculosis: morbidity, mortality, and cost implications. Transplant Proc 2001; 33:1787-1788.
13. Subramanian AK, Nuermberger EL. Tuberculosis in transplantrecipients: diagnostic and therapeutic dilemmas. Transpl Infect Dis 2008; 10:229-230.
14. Holty JE, Sista RR. Mycobacterium tuberculosis infection in transplant recipients: early diagnosis and treatment of resistant tuberculosis. Curr Opin Organ Transplant 2009; 14:613-618.
15. Hall CM, Willcox PA, Swanepoel CR, Kahn D, Van Zyl Smit R. Mycobacterial infection in renal transplant recipients. Chest 1994; 106:435-439.
16. Yildiz A, Sever MS, Turkmen A, Ecder T, Besisik F, Tabak L, et al. Tuberculosis after renal transplantation: experience of one Turkish centre. Nephrol Dial Transplant 1998; 13:1872-1875.
17. Lattes R, Radisic M, Rial M, Argento J, Casadei D. Tuberculosis in renal transplant recipients. Transpl Infect Dis 1999; 1:98-104.
18. Vandermarliere A, Van Audenhove A, Peetermans WE, Vanrenterghem Y, Maes B. Mycobacterial infection after renal transplantation in a Western population. Transpl Infect Dis 2003; 5:9-15.
19. Queipo JA, Broseta E, Santos M, Sanchez-Plumed J, Budia A, Jimenez-Cruz F. Mycobacterial infection in a series of 1261 renal transplant recipients. Clin Microbiol Infect 2003; 9:518-525.
20. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167:603-662.
21. Aguado JM, Torre-Cisneros J, Fortun J, Benito N, Meije Y, Doblas A, et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009; 48:1276-1284.
22. Torre-Cisneros J, Doblas A, Aguado JM, San Juan R, Blanes M, Montejo M, et al. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 2009; 48:1657-1665.
23. Anonymous. Mycobacterium tuberculosis, in Guidelines for the Prevention and Management of Infectious Complications of Solid Organ Transplantation. Am J Transplant 2004; 4 (Suppl 10):37-41.
24. Lui SL, Li FK, Choy BY, Chan TM, Lo WK, Lai KN. Long-term outcome of isoniazid prophylaxis against tuberculosis in Chinese renal transplant recipients. Transpl Infect Dis 2004; 6:55-56.
25. Apaydin S, Altiparmak MR, Serdengecti K, Ataman R, Ozturk R, Erek E. Mycobacterium tuberculosis infections after renal transplantation. Scand J Infect Dis 2000; 32:501-505.
26. Bliven EE, Podewils LJ. The role of chronic hepatitis in isoniazid hepatotoxicity during treatment for latent tuberculosis infection. Int J Tuberc Lung Dis 2009; 13:1054-1060.
27. Nader LA, de Mattos AA, Picon PD, Bassanesi SL, De Mattos AZ, Pineiro Rodriguez M. Hepatotoxicity due to rifampicin, isoniazid and pyrazinamide in patients with tuberculosis: is anti- HCV a risk factor? Ann Hepatol 2010; 9:70-74.
28. Fraser A, Paul M, Attamna A, Leibovici L. Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis. Cochrane Database Syst Rev 2006; 2:CD005435.
29. Cohen T, Lipsitch M, Walensky RP, Murray M. Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations. Proc Natl Acad Sci U S A 2006; 103:7042-7047.
30. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17:1-12.
31. John GT, Thomas PP, Thomas M, Jeyaseelan L, Jacob CK, Shastry JC. A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients. Transplantation 1994; 57:1683-1684.
32. Agarwal SK, Gupta S, Dash SC, Bhowmik D, Tiwari SC. Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient. Int Urol Nephrol 2004; 36:425-431.
33. Naqvi R, Naqvi A, Akhtar S, Ahmed E, Noor H, Saeed T, et al. Use of isoniazid chemoprophylaxis in renal transplant recipients. Nephrol Dial Transplant 2010; 25:634-637.
34. Vikrant S, Agarwal SK, Gupta S, Bhowmik D, Tiwari SC, Dash SC, et al. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy. Transpl Infect Dis 2005; 7:99-108.
35. Naqvi R, Akhtar S, Noor H, Saeed T, Bhatti S, Sheikh R, et al. Efficacy of isoniazid prophylaxis in renal allograft recipients. Transplant Proc 2006; 38:2057-2058.
36. El Kabbaj D, Aatif M, Moussa LA, Khassouani CE, Oualim Z. Measurement of plasma levels of isoniazid for dose adjustment in the hemodialysis patients. Saudi J Kidney Dis Transpl 2009; 20:666-667.
37. Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2010; 1:CD000171.
38. Qunibi WY, al-Sibai MB, Taher S, Harder EJ, de Vol E, al-Furayh O, et al. Mycobacterial infection after renal transplantation: report of 14 cases and review of the literature. Q J Med 1990; 77:1039-1060.
39. Chen CH, Lian JD, Cheng CH, Wu MJ, Lee WC, Shu KH. Mycobacterium tuberculosis infection following renal transplantation in Taiwan. Transpl Infect Dis 2006; 8:148-156.